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Summary The present study set out to evaluate perceptions of risk, psychological morbidity and health
behaviours in women with a family history of breast cancer who have attended genetic counselling and
determine how these differ from general population risk women. Data were collected from 62 genetic
counsellees (cases) attending the Royal Marsden and Mayday University Hospital genetic counselling services
and 62 matched GP attenders (controls). Levels of general psychological morbidity were found to be similar
between cases and controls; however, cases reported significantly higher breast cancer-specific distress despite
clinic attendance [mean (s.d.) total Impact of Event Scale score, 14.1 (14.3) cases; 2.4 (6.7) controls, P<0.001].
Although cases perceived themselves to be more susceptible to breast cancer, many women failed correctly to
recall risk figures provided by the clinic; 66% could not accurately recall their own lifetime chance. Clinics
appeared to have a positive impact on preventive behaviours and cases tended to engage more regularly in
breast self-examination (monthly, 66% of cases vs 47% of controls), although few differences were found
between groups in terms of health beliefs. We conclude that counsellees and GP controls showed considerable
similarities on many of the outcome measures, and risk of breast cancer was not predictive of greater
psychological morbidity; although cases were more vulnerable to cancer-specific distress. Despite genetic
counselling, many cases continued to perceive their risk of breast cancer inaccurately.
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Rapid developments in molecular genetics, including the
recent identification of two major breast cancer susceptibility
genes (Miki et al., 1994; Wooster et al., 1995) have advanced
understanding of the part played by familial factors in cancer
risk. A family history is widely recognised as a powerful
predictor of breast cancer (Steel et al., 1991) and is believed
to account for at least 5% of all cases (Claus et al., 1991).
These recent developments have been paralleled by a growth
in services offering genetic counselling to individuals with a
family history of breast cancer. Assessment of the
psychological impact of these services and of subsequent
participation in screening programmes has been advocated
(Houlston et al., 1992; Evans et al., 1993); however, to date,
little research has addressed these issues. Women at increased
risk because of a family history of cancer may bear a heavy
emotional burden (Wellisch et al., 1992; Kelly, 1983; Josten et
al., 1986) and a recent US evaluation of genetic counselling
services suggested 27% of clinic attenders had levels of
distress consistent with the need for psychological support
(Kash et al., 1992). Results from a population-based study of
high-risk women indicate that over a third suffer from
significant levels of breast cancer-related worry (Lerman et
al., 1993).
The effectiveness of genetic counselling is very much
dependent on attenders' comprehension of risk communica-
tions, the level of reassurance they may derive from
counselling and their willingness to adhere to medical
recommendations. The complexity of risk communication
and risk perception in relation to health issues has been noted
(Fischoff et al., 1993) and attention may need to be directed
to factors which facilitate comprehension and recall of risk
estimations.
The present study set out to provide follow-up ofattenders
of two genetic counselling clinics. The clinical service was
restricted to provision of risk estimates and advice on risk
management. Mammography or other medical follow-up was
not provided and patients' attendance was limited to a single
consultation. Details of the consultation were summarised by
a follow-up letter sent to both clinic attenders and the
referrer. The research aims were to examine psychological
and behavioural effects of genetic counselling. The study
provides data, previously unreported elsewhere, on risk
perception, psychological morbidity, health beliefs and
behaviours in high-risk women relative to a matched control
group.
Method
Participants
Cases (genetic counsellees) A consecutive series of 88 past
clinic attenders with a family history of breast cancer (mean
time since counselling, 10.9 months, range 2-25 months) at
the Royal Marsden and Mayday University Hospitals'
genetic counselling clinics, were considered for inclusion,
although eight failed to meet the study entry criteria. Of the
80 eligible attenders there was attrition in 18: six were unable
to be contacted, three patients failed to reply, one GP refusal
and eight patient refusals, giving a total of 62 assessed and a
consent rate of 85% in women contacted. The entry criteria
for cases were: aged 18 years or over; a family history of
breast cancer; literacy in English; no current treatment for
mental illness (defined as not on psychotropics); never
clinically affected with cancer; never having undergone a
prophylactic mastectomy; and resident within a radius of 100
miles. The majority of attenders were referred to the clinic by
GPs, although other sources included breast diagnostic units,
oncologists and concerned individuals themselves.
Controls A series of 62 age-matched (to within 5 years)
controls was accrued via a local general practice. Controls
were approached after their GP consultation and were invited
to participate providing they met the following eligibility
criteria: no family history of breast cancer; never clinically
affected with cancer; literacy in English; no current treatment
for mental illness (defined as above). The age range of cases
was 25-58 years, mean 40.2 years, s.d. 7.7 and controls 23-
63 years, mean, 39.9 years and s.d. 8.2.
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Procedure
Ethical approval was obtained before commencement of the
study. Cases were assessed at home and controls at the
general practice, using standardised questionnaires which had
good face validity, reliability and norms for specific reference
populations.
Outcome measures
Psychological morbidity The Brief Symptoms Inventory
(Derogatis and Spencer, 1982) is a measure of psychological
morbidity, selected on the basis that data have been collected
on a similar sample of high-risk women (Kash et al., 1992)
and previous use in an evaluation of the psychological
functioning of daughters of breast cancer patients (Wellisch
et al., 1991). Although norms for this measure are derived
from American samples, it was selected primarily for
comparison purposes.
The Impact of Event Scale (Horowitz et al., 1979) was
previously used as a measure of coping with response to a
single traumatic event. This measure was adapted to gather
information on cancer-specific distress (Kash et al., 1992). It
provides indices on intrusive thoughts (level of preoccupation
with breast cancer, 'I thought about it when I didn't mean
to') and avoidance (use of denial as a coping strategy, 'I tried
to remove it from memory'). An opt-out box was included
for women who had not thought about breast cancer in the
last week.
Risk perception (cases only) Derived from Kash et al.
(1992), this measure assessed retention of specific genetic
risk information communicated at the clinic: (1) personal
chances of breast cancer (1 in ... figure); (2) annual
percentage chance of breast cancer; and (3) relative risk
(chances compared with other women, i.e. average, above
average, below average).
Early diagnostic behaviours Several reliable and prevalidated
items (Kash et al., 1992; Evans et al., 1985) which assessed
specific health behaviours related to early detection: breast
self-examination, mammography and clinical breast examina-
tion. However, controls were only asked about breast self-
examination, since it was unlikely that the majority of
controls would have experience of mammography or regular
clinical breast examination (only seven controls were over 50
years and eligible for the national screening programme).
Additional items assessed use of hormone replacement
therapy, uptake of cervical smears and participation in the
tamoxifen trial in cases.
Health beliefs (Kash et al., 1992) Included variables which,
according to the health belief model (Janz and Becker, 1984),
explain uptake of a preventative health behaviour: (1)
barriers, perceived benefits and attitudes towards early
diagnostic methods; (2) perceived severity of breast cancer;
(3) cues to action (i.e. reminder methods).
Clinic evaluation An in-house scale (cases only). Items were
included which assess the effectiveness of the clinics and
covered benefits or otherwise of attendance, views on how
reassuring the genetic consultation was felt to be and
comments on action advised.
Statistical method
Analyses were performed using the SPSS package. All tests
between cases and controls incorporated the matched nature
of the data. Parametric (paired t-test) or non-parametric
(Wilcoxon matched pairs signed-rank test, McNemar's test,
Kruskal-Wallis test) were used as appropriate for the nature
and distribution of the data. One-tailed tests were used where
a priori predictions were made about the direction of the
differences between groups. All other tests were two-tailed.
The possibility of false-positive results arising, given the high
number of statistical tests carried out, is acknowledged. The
data have been interpreted and presented with this in mind
and, where appropriate, percentages are followed with 95%
confidence intervals (95% CI) in preference to giving a P-
value.
Results
The data indicated that cases and controls were generally
similar on employment, marital status and social class,
although there were more social classes I and II in the case
sample (49% of cases, 34% of controls).
Psychological morbidity
Cases and controls were similar with regard to scores on the
Brief Symptom Inventory with the exception of somatisation
(P<0.01), controls scoring higher on this dimension [mean,
49 (s.d. 8.6) for cases; 54.7 (s.d. 10.0) for controls]. Using a
cut-off global severity score or any two primary dimension
scores of 63 and over (Derogatis and Spencer, 1982), 31%
(95% CI 19%-43%) ofcases and 34% (95% CI 22%-46%)
of controls had levels of psychological symptoms consistent
with the need for psychological counselling. Specific cancer
distress, as assessed by the Impact of Event Scale, was
significantly higher in cases than controls (see Table I) on
intrusion, avoidance and total score with 65% of cases and
16% of controls indicating that they had thought about
breast cancer in the last 7 days.
Risk perception
A self-report item assessed women's perception of risk before
clinic attendance. The majority of cases (58%) stated that
they had overestimated their risk of breast cancer before
genetic counselling, a further 32% stated that they had
estimated their risk correctly and 10% reported that they had
underestimated their risk.
Regarding post-clinic attendance, a total of 74% (95% CI
63% -85%) of cases rated themselves to be at 'above
average' risk compared with 11% (95% CI 3%-19%) of
controls when they estimated their chances of developing
breast cancer relative to other women. Figure 1 illustrates the
distribution of case and control responses in terms of
Table I Case and control scores for the Impact of Event scale
Max. Cases Controls
Dimension score Mean (s.d.) Mean (s.d.) P-value
Intrusion 35 6.9 (7.4) 1.1 (3.5) <0.001
Avoidance 40 7.2 (8.5) 1.3 (3.8) <0.001
Total IES 75 14.1 (14.3) 2.4 (6.7) <0.001
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Figure 1 Perceived and actual lifetime chance of breast cancer.
1 , cases perceived risk (n=54); _, cases actual risk (n=61);
_, controls perceived risk (n=41).Familial breast cancer and psychological morbidity
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estimated lifetime chance of developing breast cancer (modal
score: cases, 1 in 5; controls, 1 in 50). Calculations of actual
risk were made from pedigree data obtained at the clinic and
analysed by the geneticist, using the CASH model (Claus et
al., 1991). This model assesses risk of breast cancer using
information derived from the number of affected first and
second degree relatives and their age at diagnosis. Compar-
ison between CASH risk figures and perceived lifetime risk
indicated that 17.7% of cases overestimated their chances of
breast cancer (defined as any perceived risk greater than the
CASH risk), 19.4% estimated their changes correctly (a
perceived risk that matched the CASH risk) and 48.4% gave
an underestimated (any risk less than the CASH risk),
indicating an overall inaccuracy of 66.1%. Accuracy of recall
was not correlated with time lapsed since clinic attendance
(P =0.18). Overall 76% ofcontrols provided overly optimistic
estimations of their risk (any response greater than the
general population risk, i.e. from 1 in 20 to 1 in 100). Missing
values can be accounted for by 14.5% of cases and 34% of
controls who were unable to provide a precise figure or rated
their lifetime chance as 'don't know'.
CASH risk figures were found to be marginally associated
with cases' perceived lifetime chance of getting breast cancer
(expressed as a 1 in ... figure), (P=0.03) but were unrelated
to perception of relative risk compared with other women,
measures of mental health or extent to which cases engaged
in breast self-examination. Again, no association was found
between perceived risk of breast cancer relative to other
women (average, above average, below average) and
perception of lifetime chance of breast cancer (1 in ...
figure) (Figure 2).
A high perceived lifetime risk was associated with
increased scores on the intrusion and avoidance subscales
of the Impact of Event scale (P<0.05 and 0.01 respectively).
There was no association with the general severity index of
the Brief Symptoms Inventory. In addition an 'above
average' perceived risk relative to general population women
was positively associated with increased scores on the
intrusion and avoidance subscales of the Impact of Event
scale (P<0.001).
Few women (13%) could recall their annual percentage
chance of developing breast cancer despite this information
being reiterated in clinic follow-up letters. Some 56% (95%
CI 43%-69%) of cases and 41% (95% CI 26%-56%) of
controls knew the risk of breast cancer in the general
population.
Early diagnostic behaviours
Mammography In all 68% of cases had a mammogram at
some point in their lives, 11% of the case sample qualified for
the national mammographic screening programme. Although
mammography is normally confined to women aged 50 years
and over, age was unrelated to having had a mammogram.
Actual risk, CASH model
No association Marginal
association
(P = 0.03)
Perceived Perceived
relative * lifetime
risk No association risk
Figure 2 Relationship between actual risk (CASH model, Claus
et al., 1991) and perceived risk.
As mammograms are offered with long time intervals
between, the interval between genetic counselling and
administration of the questionnaire was examined but this
did not affect reported mammography.
Breast self-examination High compliance rates were indi-
cated in both groups, with 90% (95% CI 83%-97%) of
cases and 76% (95% CI 65%-87%) of controls indicating
that they examined their breasts. Cases and controls were
similar in their frequency of carrying out breast self-
examination. The majority of participants stated that they
carried out the procedure on a monthly basis (66% cases,
47% controls), although within this category a subgroup
(18% cases, 9% controls) indicated that they examined their
breasts more frequently than the recommended once a
month. Most participants stated that they adhered to the
recommended time to engage in breast self-examination i.e.
'after their period' (39% of cases, 21% ofcontrols). Controls
were more likely to carry out self-examination in a haphazard
fashion, (i.e. responded with 'whenever I think of it', 32% of
cases, 60% ofcontrols). Altogether 25% of cases and 15% of
controls indicated that they were examining their breasts
outside the recommended time e.g. 'before or during their
period'. Uptake and frequency of breast self-examination was
unrelated to marital and employment status, social class and
age. In addition, no association was found between uptake
and the general anxiety dimension of the Brief Symptoms
Inventory.
Cases indicated the impact of the clinic on uptake of
early diagnostic behaviour by comparing their rates of
mammography, breast self-examination and clinical breast
examination pre-clinic attendance with rates post-clinic. A
total of 40% of cases reported increased rates of breast self-
examination following genetic clinic attendance (Table II).
Other health behaviours (cases) Some 14.5% of cases were
on hormone replacement therapy, 96.8% had had a cervical
smear and 3.2% were participating in the tamoxifen trial.
Health beliefs
Data on perceived barriers indicated that few difficulties
existed in terms of cases monitoring their health in relation to
their breasts (Table III).
Attitude to mammography This was assessed by four
attitude items (Table IV). The majority of women disagreed
with the statements 'mammograms cause unnecessary worry'
and that 'mammograms expose women to excessive radia-
tion'. In contrast, the statements 'regular screening means
fewer deaths' and 'mammography reveals cancers before they
can be felt' met with considerable agreement indicating a
generally favourable attitude towards mammography in this
sample.
Cases and controls were no different on items assessing
perceived benefits of breast self-examination and were
similarly confident in their own ability to carry out breast
self-examination. Although barriers to self-examination were
only measured by this single item, it is clear cases find the
Table H Reported changes in rates of breast self-examination,
clinical breast examination and mammography following genetic
counselling
Changes in rates Clinical
since genetic Breast self- breast
counselling examination Mammography examination
Less often 3 (5%) 10 (17%) 8 (14%)
More often 25 (40%) 14 (25%) 8 (14%)
The same 34 (55%) 33 (58%) 41 (72%)
Total 62 57 57Table HI Perceived barriers to early diagnostic methods (cases)
Barrier 0 1 2 3 4
Physical 41 4 4 1 2
discomfort of 79% 8% 8% 2% 4%
mammography
Fear of findings 41 3 5 4 4
72% 5% 9% 7% 7%
Transport to 55 1 2 0 0
screening clinic 95% 2% 3% 0% 0%
Find screening 41 6 4 4 3
visit distressing 71% 10% 7% 7% 5%
Taking time off 44 2 5 6 1
for screening 76% 3% 9% 10% 2%
Having to examine 45 3 3 4 7
your own breasts 73% 5% 5% 7% 11%
0, not difficult; 4, very difficult.
Table IV Attitudes towards mammography (cases)
Strongly Somewhat Somewhat Strongly
agree agree disagree disagree
Attitude n % n % n % n %
Mammograms
cause worry 1 1.6 8 13.1 18 29.5 34 55.7
Mammograms
expose to
excessive
radiation 0 0 15 25.4 28 47.5 16 27.1
Regular screening
means fewer
deaths 46 75.4 14 23.0 1 1.6 0 0
Mammography
reveals cancers
before they can
be felt 44 73.3 13 21.7 2 3.3 1 1.7
procedure difficult and some women commented to this effect
as they were completing the questionnaire; for example, one
remarked that she had had to stop examining her breasts as it
made her anxious: every month she had thought 'is this the
month that I will find a lump that will kill me?'
Cases and controls universally perceived breast cancer to
be a 'serious' disease.
The number of cases reminded by their doctors to have
breast screening (cues to action) was 15%. Cases and controls
were similar in terms of reading leaflets or having had a
demonstration of breast self-examination, or being encour-
aged to perform the procedure by friends, a spouse, a doctor
or nurse [although 29% (95% CI 16%-42%) of cases were
more likely to report encouragement from 'other relatives'
compared with 0% of controls]. Controls were far less likely
than cases to have a reminder method for examining
themselves [9% (95% CI 0.1%-17%) and 41% (95% CI
28% -54%) respectively].
Clinic evaluation Most clinic attenders reported that they
found their consultation reassuring (79%). Of the rest, three
individuals indicated that they found the clinic 'not
reassuring' (5%) and a further 16% selected the 'neither'
option. The majority of attenders found the consultation
'very or highly effective' (82%), with 15% considering it
"somewhat effective' and only 3% saying that it was
'ineffective'. An open-ended question asked for brief
comments about the benefits or otherwise of attending this
clinic. The most common comment was that the clinic helped
put attenders 'mind at rest'. Many women mentioned that
they found it beneficial to receive information about breast
cancer and their specific risks given their family history.
Familial breast cancer and psychological morbidity
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Earlier access to mammograms and the opportunity to
contribute to cancer research were also mentioned as
beneficial.
Other results
Otherfamily members' counselling needs In all 71% of cases
reported that they had other family members at risk of
hereditary breast cancer and 34% had sent a copy of their
clinic summary letter to relatives. Some 23% indicated that
other family members had also attended the clinic.
Bereavement and adjustment to being at risk of hereditary
cancer Relative to the general population this group of
women is likely to have experienced considerably more
bereavement. Not surprisingly, therefore, a proportion of
women spontaneously mentioned such bereavement issues
during the course of the interview, although this was not
specifically assessed within our questionnaire. Two indivi-
duals had experienced their mother's death in the month
before completing the questionnaire, and two others
explained that they had terminally ill relatives and this may
have influenced their responses. One woman who had had
five female relatives die from breast cancer stated that she felt
the clinic visit had been a traumatic experience and indicated
that she would have welcomed an opportunity for some form
of follow-up to enable her to express her grief. However,
several women who had attended the clinic immediately after
the death of a family member explained that they found the
clinic helpful in the grieving process. Thus the clinic may
have the potential to play a significant role in the emotional
adjustment of women to their risk status and the bereave-
ment they experience.
Criticism of and needs not addressed by the clinic One
woman commented that she found the information too
statistical. One commented that 'to them its just numbers, to
me it's my life'. Another participant stated that although she
found it beneficial to understand her relative chances of
breast cancer she had not found clinic attendance helpful.
Several women felt that there was not sufficient emphasis
placed on action they could take regarding their risk. 'I don't
want to think about the risks of cancer, I want to think
about how I can prevent it'. Also mentioned were concerns
about the roles of stress and diet in the development of
cancer which receives less attention in consultations.
Discussion
We have examined current perception of risk, mental health,
specific cancer worries and health beliefs in relation to risk
management, in a group of women who attended for genetic
counselling because of a family history of breast cancer. The
inclusion of age-matched GP controls provided a reference
population against which to compare these factors.
A striking and highly significant difference was apparent
between counselled women and the GP control group in
terms of cancer-specific distress, suggesting that high-risk
women experience breast cancer-related worries that are not
assuaged by genetic counselling. A more extensive prospective
study is currently being conducted which should clarify this
issue. High levels of cancer anxiety may reflect a sense of
frustration that some women feel, once informed that they
fall within a high-risk category, yet little may be offered to
them in terms of primary prevention. Several women
commented that, while they understood they had an
increased risk of breast cancer, they had a less clear-cut
picture of what they could do to manage that risk. Although
no relationship was observed between the geneticist's risk
figure and cancer distress, our data suggest that women's own
perceptions of risk are associated with breast cancer worry.
Against initial predictions, counselled women and GP
controls were similar on measures of general mental health,Familial breast cancer and psychological morbidity
S Lloyd et al
as assessed by the Brief Symptoms Inventory, with the
exception of significantly higher levels of somatisation in the
control group. Since recruitment ofcontrols was via a general
practice surgery such findings are likely to reflect an excess of
genuine physical symptoms within this sample. In a
comparison study of daughters of breast cancer patients
and general population risk women again no differences were
found on this measure, (Wellisch et al., 1991) and levels of
psychological morbidity are similar to the 27% reported by
Kash et al. (1992) in a US group of high-risk women.
Equivalent rates found in our GP sample may, however,
bring the Kash figure into perspective, and confirm the
benefits of providing a reference population.
No relationship emerged between the general anxiety
dimension of the Brief Symptom Inventory and performance
of breast self-examination within the case group. This is
contrary to fear arousal communication theory (Janis and
Feschbach, 1953) and previous findings (Kash et al., 1992)
reporting a negative relationship between anxiety and early
detection behaviour. To some extent this may be explained by
sampling method, since those attending a genetic counselling
clinic may be those most motivated to carry out health-
related behaviour and characteristically have optimum levels
of anxiety (Hailey, 1991).
Despite clinic attendance, 66.1% of cases continued to
either under- or overestimate their lifetime risk suggesting a
failure to understand or retain precise risk information. The
number ofmissing values and 'don't know' responses for this
item also suggests that women find risk information
presented in an odds ratio format confusing and this
requires further investigation. A recent prospective study of
risk communication (Evans et al., 1994) again provides data
that a high proportion of women fail to recall personal risk
information accurately or corresponding general population
figures one year after attending genetic counselling.
Although the majority of cases were unable to recall their
lifetime risk precisely, a marginally significant association
between cases' perceived lifetime risk (expressed as a 1 in ...
probability) and the geneticist's figures suggests that their
estimations were not always far off the mark. No association
was found between CASH calculations and women's
perception of their risk relative to the general population.
This suggests that many women are failing to translate
numerical risk information into whether or not they are more
or less likely than average to develop breast cancer. Other
studies have also highlighted the diversity of responses that
individuals make when requested to convert numerical risks
to verbal categories (Shiloh and Sagi, 1989) and some of this
discrepancy may be accounted for by poor recall of breast
cancer prevalence rates in the general population as suggested
by our data. In addition, the three point response scale to
assess perceived relative risk may have imposed some
limitations, reducing the overall sensitivity of this measure.
The majority of cases claimed to have overestimated their
risk of breast cancer before attending the clinic suggesting
that they may have been overly concerned about breast
cancer. Evans et al. (1993) report a greater precounselling
tendency for genetic counsellees to underestimate their risk,
which may be a reflection of our differing assessment
methods, i.e. retrospective in this study, vs at the time of
clinic for Evans et al. (1993) and differing criteria for
assessing over- and underestimation [Evans et al. (1993)
take into account those who over- or underestimate by more
than 50%]. Post-clinic attendance, the majority of our cases
underestimated their risk; this may suggest that false
reassurance was derived from the consultation or that
women are failing to understand the figures. Alternatively,
underestimation may represent a psychological defence and
further investigation should attempt to clarify this issue.
Results in terms of adherence to early diagnostic
behaviours were of specific interest. Of particular note were
the high rates ofreported breast self-examination by high-risk
women and these fall in line with the existing literature [Kash
(1992) similarly reported rates of 90% albeit again practised
on an ad hoc basis]. Reported breast self-examination by
controls was also high [14-40% of general population
women have previously been reported to carry out self-
examination on a monthly basis (Lauver and Angerame,
1988)]. This was despite there being no consistent advice
given at the clinic concerning this practice of unproven
benefit. As with our findings, lack of confidence has
previously been cited as a barrier to adoption of this
secondary prevention technique (Rutledge and Davis, 1988).
Despite clinic attendance, 10% of high-risk women reported
that they do not perform breast self-examination. A
significant minority of women were uncomfortable with
examining their breasts, although in this study barriers to
breast self-examination were not assessed in those who failed
to carry it out. It is notable that the difference between cases
and controls in the percentage practising monthly breast self-
examination was not large although clinic attenders reported
that they had significantly increased their use of this
unproven screening method as a result of genetic counselling.
Useful information was gathered in relation to health beliefs
surrounding mammography. Results indicate that the vast
majority of genetic clinic attenders did not perceive many
difficulties in attending for screening. However, only 15% of
cases received reminders from their doctors to attend breast
screening and such cues have previously been identified as
influential inpromotingcompliance (Vogel etal., 1990). Recent
UKreports againsuggestthatgeneralpractitionersandpractice
nurses may not be taking up valuable opportunities to promote
screening participation (Austoker, 1994).
Attitude towards mammography was generally favourable,
although a few women felt that mammography exposed them
to excessive radiation and a number of women stated that
they felt that undergoing a mammogram caused them
unnecessary worry. In relation to health beliefs, breast
cancer was universally perceived as an extremely serious
disease which may be a reflection of ever increasing media
attention, high general population incidence rates and greater
awareness created by the introduction of a national screening
programme.
Generalisation of our findings should be made with
caution since the study is retrospective in design and
participants were selected from only two cancer family
clinics and a single general practice. Many women in our
case sample actively sought a referral to the cancer family
clinic by approaching their GP for early screening, suggesting
a high level of motivation in this sample. Future studies
should document source of clinic referral and compare
women actively seeking genetic counselling with those
attending due to recommendation of a doctor.
Clinical implications
Feedback concerning the clinic was generally very favourable,
with the vast majority of attenders finding the consultation
reassuring, although a significant number still had specific
cancer-related worries as indicated by our results. Such clinics
may provide an important role in the emotional adjustment
of high-risk women who commonly bear a heavy psycholo-
gical burden from their familial experiences of breast cancer
and unusually high bereavement rates. It may be beneficial if
clinics can have resources to provide psychological support,
with the aim of alleviating excessive breast cancer worry,
reducing psychological barriers to secondary prevention,
aiding decisions regarding prophylactic surgery and provid-
ing counselling for unresolved bereavement reactions.
In terms of educating women about their risk, it is clear
that this goal of genetic counselling was only partially
attained. There was a failure by two-thirds of those
counselled to either comprehend or recall their given risk
estimates accurately, despite being sent a follow-up letter
summarising the consultation; the benefits of providing
annual percentage risk figures is questionable. It may be
the 'reassurance' a women receives in the clinic about her
chance of breast cancer, or the advice about future screening,Familial breast cancer and psychological morbidity
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that is of primary importance. Clinic attendance appears to
have influenced uptake of breast self-examination suggesting
that, despite this being an unproven screening method, many
high-risk women wish to do something themselves to help
them manage their risk of breast cancer. It has also been
argued that, since over 90% of breast cancers are found by
women themselves, there is a need to optimise this method of
detection (Austoker, 1994). One of the most important
benefits of genetic counselling is that women attending will
subsequently take charge oftheir risk rather than feel helpless
when their high-risk status is confirmed.
Future research
The recent cloning of the breast-ovarian cancer suscept-
ibility gene (BRCA1), and a second breast cancer suscept-
ibility gene (BRCA2), will have a considerable impact on
genetic counselling services. Recent estimates suggest that as
many as 1 in 800 women may carry a BRCA1 mutation
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